Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XNCR Xencor Inc

盘前交易 05-08 04:25:31 EDT

24.24

-0.07

-0.29%

最高24.60	最低23.92	成交量85.85万
今开24.51	昨收24.31	日振幅2.80%
总市值14.94亿	流通市值13.51亿	总股本6,165万
成交额2,079万	换手率1.54%	流通股本5,575万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":24.24,"timestamp":1715112000000,"preClose":24.31,"halted":0,"volume":858549,"delay":0,"floatShares":55753968,"shares":61647493,"eps":-2.083969,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.07,"latestTime":"05-08 04:25:31 EDT","open":24.51,"high":24.6,"low":23.92,"amount":20787247.627880998,"amplitude":0.027972,"askPrice":26.58,"askSize":100,"bidPrice":22.04,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.083969,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715175000000},"adr":0,"listingDate":1386046800000,"adjPreClose":24.24,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":24.24,"preClose":24.24,"latestTime":"16:59 EDT","volume":17969,"amount":435568.56,"timestamp":1715115544642},"volumeRatio":0.8959704605634395},"requestUrl":"/m/hq/s/XNCR","defaultTab":"news","newsList":[{"id":"2432276973","title":"Xencor Inc    预计每股亏损 79 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432276973","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432276973?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:48","pubTimestamp":1714736887,"startTime":"0","endTime":"0","summary":"   * Xencor Inc    预计将在5月6日公布截至2024年3月31日的业绩报告(估计)，季度收入将有所增长。* 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于加利福尼亚州帕萨迪纳的公司的营收将从去年同期的1896万美元增长31.8%，达到2499.2万美元。* LSEG 分析师对 Xencor Inc 的平均预期是每股亏损 79 美分。* 华尔街对 Xencor Inc 的 12 个月目标价中位数为 34.00 美元，高于其最新收盘价 23.63 美元。5月3日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432570965","title":"Xencor, Inc.盘中异动 股价大涨5.25%报22.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570965","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432570965?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:39","pubTimestamp":1714570746,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时39分，Xencor, Inc.股票出现异动，股价快速上涨5.25%。截至发稿，该股报22.04美元/股，成交量3.7678万股，换手率0.06%，振幅5.11%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tg Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为467.77%、40.06%、16.09%，振幅较大的相关个股有Promis Neurosciences Inc.、Carmell Corporation、Cytomx Therapeutics, Inc.，振幅分别为30.95%、21.50%、20.25%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121390787e852bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121390787e852bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431818850","title":"Xencor, Inc.盘中异动 股价大涨5.06%报20.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431818850","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431818850?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:36","pubTimestamp":1714408580,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时36分，Xencor, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报20.99美元/股，成交量10.7483万股，换手率0.17%，振幅4.61%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000362187e84cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000362187e84cab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430788937","title":"Xencor, Inc.盘中异动 大幅上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430788937","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430788937?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:16","pubTimestamp":1714148184,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时16分，Xencor, Inc.股票出现异动，股价快速上涨5.12%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1355.05%、118.82%、46.73%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为82.78%、81.90%、66.85%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700162479240bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700162479240bce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428660589","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.07%报17.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660589?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:10","pubTimestamp":1713550220,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时10分，Xencor, Inc.股票出现异动，股价大幅下挫5.07%。截至发稿，该股报17.99美元/股，成交量34.5774万股，换手率0.57%，振幅5.17%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。该公司利用其XmAb技术平台开发候选抗体产品，如XmAb5871和XmAb7195。该信息摘要如下：BTIG：维持Xencor评级，由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200210217a54284f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200210217a54284f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428187767","title":"BTIG：维持Xencor(XNCR.US)评级，由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428187767","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428187767?lang=zh_cn&edition=full","pubTime":"2024-04-17 00:15","pubTimestamp":1713284107,"startTime":"0","endTime":"0","summary":"BTIG：维持Xencor(XNCR.US)评级，由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170015138784e7d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170015138784e7d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427202598","title":"Xencor, Inc.盘中异动 大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427202598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427202598?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:42","pubTimestamp":1713274973,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时42分，Xencor, Inc.股票出现异动，股价快速下挫5.07%。截至发稿，该股报19.09美元/股，成交量3.8176万股，换手率0.06%，振幅2.39%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Jaguar Health, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cullinan Oncology, Inc.涨幅较大，Biorestorative Therapies, Inc.、Jaguar Health, Inc.、Soligenix, Inc.较为活跃，换手率分别为100.32%、34.08%、32.82%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Brainstorm Cell Therapeutics Inc.、Marinus Pharmaceuticals, Inc.，振幅分别为101.56%、21.87%、21.54%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621425387e80fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621425387e80fa3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419816361","title":"Xencor, Inc.盘中异动 大幅拉升5.04%报23.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419816361","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419816361?lang=zh_cn&edition=full","pubTime":"2024-03-16 02:52","pubTimestamp":1710528739,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日02时52分，Xencor, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报23.14美元/股，成交量42.8812万股，换手率0.70%，振幅5.13%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Xencor, Inc.公司简介：Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316025219861debbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316025219861debbb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418318901","title":"Xencor, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418318901","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418318901?lang=zh_cn&edition=full","pubTime":"2024-03-12 03:52","pubTimestamp":1710186761,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日03时52分，Xencor, Inc.股票出现异动，股价急速跳水5.03%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Aslan Pharmaceuticals Limited、Tc Biopharm  Plc C/Wts 10/02/2028 、Finch Therapeutics Group, Inc.涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Transcode Therapeutics, Inc.较为活跃，换手率分别为5699.30%、197.62%、120.51%，振幅较大的相关个股有Aslan Pharmaceuticals Limited、Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为203.84%、152.82%、145.83%。Xencor, Inc.公司简介：Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031203524187e77d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031203524187e77d62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416964852","title":"Xencor, Inc.2023财年实现净利润-1.26亿美元，同比减少128.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964852","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416964852?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:24","pubTimestamp":1709396643,"startTime":"0","endTime":"0","summary":"12月31日，Xencor, Inc.公布财报，公告显示公司2023财年净利润为-1.26亿美元，同比减少128.34%；其中营业收入为1.68亿美元，同比增加1.82%，每股基本收益为-2.08美元。从资产负债表来看，Xencor, Inc.总负债2.84亿美元，其中短期债务9.77百万美元，资产负债比为3.36，流动比率为0.08。机构评级：截至2023年12月31日，当前有12家机构对Xencor, Inc.目标价做出预测，其中目标均价为37.33美元，其中最低目标价为22.00美元，最高目标价为58.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300241087dcec01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300241087dcec01&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414471831","title":"Xencor Inc盘中异动 早盘快速上涨5.19%报25.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414471831","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414471831?lang=zh_cn&edition=full","pubTime":"2024-02-27 00:14","pubTimestamp":1708964066,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日00时14分，Xencor Inc股票出现异动，股价急速拉升5.19%。截至发稿，该股报25.74美元/股，成交量26.446万股，换手率0.43%，振幅5.03%。Xencor Inc股票所在的生物技术行业中，整体跌幅为0.11%。Xencor Inc公司简介：Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270014277a46f2b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270014277a46f2b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413031745","title":"Xencor Inc    预计每股亏损 9 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413031745","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413031745?lang=zh_cn&edition=full","pubTime":"2024-02-24 08:14","pubTimestamp":1708733678,"startTime":"0","endTime":"0","summary":"   * Xencor Inc    将于2月27日公布截至2023年12月31日的季度财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于加利福尼亚州帕萨迪纳的公司的营收预计将从去年同期的2161万美元增长241.7%，达到7384.3万美元。* LSEG 分析师对 Xencor Inc 的平均预期为每股亏损 9 美分。* 华尔街对 Xencor Inc 的 12 个月目标价中位数为 36.50 美元，高于其 24.47 美元的最新收盘价。2月24日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412836163","title":"Xencor Inc    预计每股亏损 9 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412836163","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412836163?lang=zh_cn&edition=full","pubTime":"2024-02-20 05:14","pubTimestamp":1708377252,"startTime":"0","endTime":"0","summary":"   * Xencor Inc    预计将在2月21日公布的截至2023年12月31日的业绩报告中显示季度收入增长(预计)    * 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于加利福尼亚州帕萨迪纳的公司的营收预计将从去年同期的2161万美元增长241.7%，达到7384.3万美元。* LSEG 分析师对 Xencor Inc 的平均预期为每股亏损 9 美分。* 华尔街对 Xencor Inc 的 12 个月目标价中值为 36.50 美元，高于其 24.15 美元的最新收盘价。2月19日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412660503","title":"Xencor Inc盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412660503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412660503?lang=zh_cn&edition=full","pubTime":"2024-02-17 00:37","pubTimestamp":1708101460,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日00时37分，Xencor Inc股票出现波动，股价急速上涨5.16%。Xencor Inc股票所在的生物技术行业中，整体涨幅为0.29%。Xencor Inc公司简介：Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240217003740861d591c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240217003740861d591c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411353150","title":"Xencor Inc盘中异动 股价大涨5.02%报20.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411353150","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411353150?lang=zh_cn&edition=full","pubTime":"2024-02-15 05:00","pubTimestamp":1707944415,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日05时00分，Xencor Inc股票出现异动，股价急速拉升5.02%。截至发稿，该股报20.08美元/股，成交量29.693万股，换手率0.49%，振幅3.97%。Xencor Inc股票所在的生物技术行业中，整体涨幅为1.31%。Xencor Inc公司简介：Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402150500157a43b1ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402150500157a43b1ab&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":0.1576},{"period":"1month","weight":0.1386},{"period":"3month","weight":0.2963},{"period":"6month","weight":0.4664},{"period":"1year","weight":-0.1134},{"period":"ytd","weight":0.1418}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月，2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司，专注于发现和开发工程化的单克隆抗体和细胞因子疗法，以治疗癌症和自身免疫性疾病患者，这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解，并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.034038},{"month":2,"riseRate":0.636364,"avgChangeRate":0.063869},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.028292},{"month":4,"riseRate":0.090909,"avgChangeRate":-0.044452},{"month":5,"riseRate":0.636364,"avgChangeRate":0.046911},{"month":6,"riseRate":0.7,"avgChangeRate":0.127212},{"month":7,"riseRate":0.5,"avgChangeRate":-0.012249},{"month":8,"riseRate":0.5,"avgChangeRate":-0.001995},{"month":9,"riseRate":0.3,"avgChangeRate":-0.039286},{"month":10,"riseRate":0.4,"avgChangeRate":-0.022982},{"month":11,"riseRate":0.9,"avgChangeRate":0.139418},{"month":12,"riseRate":0.6,"avgChangeRate":0.028545}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况